Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer? Request a free trial to our platform.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Enabling competition in pharmaceutical markets

Flag for USA Brookings Institution on May 2nd 2017
Fiona Scott Morton and Lysle Boller
The United States, unlike many other industrialized nations, does not regulate the price of pharmaceutical products directly. There are advantages to this approach. The U.S. generic market is one o…

Topics in this document

Related SDGs

SDG 3: Good Health and Well-being ...
SDG 3: Good Health and Well-being

Target 3.b

Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Citations

Cited by 18 other policy documents (13 of them are from other policy sources)

This document is made up of multiple PDFs

The references found in each have been combined below. If an item has been cited in more than one PDF then it'll appear more than once, linked to the relevant PDF and page number.